Latest News about BMY
Recent news which mentions BMY
After FDA, European Agency Limits Use Of Certain JAK Inhibitors Amid Safety Concerns
October 31, 2022
From Benzinga
Analyst Sees Market Potential For Arcellx Multiple Myeloma Candidate, Sees 50% Upside In Stock
October 27, 2022
From Benzinga
From Benzinga
If You Invested $10,000 in Bristol Myers Squibb 5 Years Ago, This Is How Much You Would Have Today
October 27, 2022
Tickers
BMY
From Motley Fool
This Company Is Racing Toward Providing Comfort And Safety To Millions Of Psoriasis Sufferers
October 27, 2022
From Benzinga
Tickers
BMY
From Motley Fool
Bristol Myers Squibb (BMY) Q3 2022 Earnings Call Transcript
October 26, 2022
Tickers
BMY
From Motley Fool
Two Warren Buffett Rules You Should Never Forget
October 26, 2022
From Motley Fool
Revlimid Generic Competition, Forex Impacts Bristol Myers' Q3 Sales; Reaffirms FY22 Guidance
October 26, 2022
Tickers
BMY
From Benzinga
Nasdaq, S&P 500 Futures Lower Following Alphabet, Microsoft Earnings
October 26, 2022
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
October 25, 2022
From Benzinga
2 Pharma Stocks With Blockbuster Drugs on the Horizon
October 25, 2022
From Motley Fool
2 No-Brainer Healthcare Stocks to Buy Right Now
October 24, 2022
From Motley Fool
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
October 23, 2022
From Motley Fool
3 Dirt-Cheap Stocks to Buy Sooner Rather Than Later
October 22, 2022
From Motley Fool
New Data Reinforce Benefits Of Bristol Myers's Opdivo In Earlier Stages Of Melanoma
October 20, 2022
Tickers
BMY
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
October 19, 2022
From Benzinga
Why Legend Biotech's Shares Jumped 14.2% On Tuesday
October 18, 2022
From Motley Fool
What Is Going on With AVEO Pharmaceuticals (AVEO) Stock Today?
October 18, 2022
From InvestorPlace
Jupiter Wellness's Potential New OTC Drug Could Put Some More Joy Back Into Breast Cancer Survivors' Lives
October 18, 2022
From Benzinga
3 Fast-Growing Medical Dividend Stocks
October 17, 2022
From Motley Fool
Peering Into Bristol-Myers Squibb's Recent Short Interest
October 13, 2022
Tickers
BMY
From Benzinga
Got $5,000? These 2 Stocks Could Continue Beating the Bear Market.
October 12, 2022
From Motley Fool
The 7 Most Undervalued Value Stocks to Buy Now
October 10, 2022
From InvestorPlace
What 6 Analyst Ratings Have To Say About Bristol-Myers Squibb
October 10, 2022
Tickers
BMY
From Benzinga
Will Chart Analysts Notice Bad Omen on Bristol-Myers Squibb's Chart
October 10, 2022
Tickers
BMY
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2022
October 10, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.